BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 17980882)

  • 1. Enhanced removal of cholesterol from macrophage foam cells to serum from type IV hypertriglyceridemic subjects.
    Attia N; Ramaharo A; Paul JL; Cambillau M; Beaune P; Grynberg A; Simon A; Fournier N
    Atherosclerosis; 2008 May; 198(1):49-56. PubMed ID: 17980882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced efflux of cholesterol from ABCA1-expressing macrophages to serum from type IV hypertriglyceridemic subjects.
    Fournier N; Francone O; Rothblat G; Goudouneche D; Cambillau M; Kellner-Weibel G; Robinet P; Royer L; Moatti N; Simon A; Paul JL
    Atherosclerosis; 2003 Dec; 171(2):287-93. PubMed ID: 14644399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of android overweight or obesity and insulin resistance on basal and postprandial SR-BI and ABCA1-mediated serum cholesterol efflux capacities.
    Attia N; Fournier N; Vedie B; Cambillau M; Beaune P; Ziegler O; Grynberg A; Paul JL; Guerci B
    Atherosclerosis; 2010 Apr; 209(2):422-9. PubMed ID: 19837407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced synthesis of the oxysterol 24(S),25-epoxycholesterol in macrophages by inhibitors of 2,3-oxidosqualene:lanosterol cyclase: a novel mechanism for the attenuation of foam cell formation.
    Rowe AH; Argmann CA; Edwards JY; Sawyez CG; Morand OH; Hegele RA; Huff MW
    Circ Res; 2003 Oct; 93(8):717-25. PubMed ID: 14512442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of different cellular models measuring in vitro the whole human serum cholesterol efflux capacity.
    Mweva S; Paul JL; Cambillau M; Goudouneche D; Beaune P; Simon A; Fournier N
    Eur J Clin Invest; 2006 Aug; 36(8):552-9. PubMed ID: 16893377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export.
    Du XM; Kim MJ; Hou L; Le Goff W; Chapman MJ; Van Eck M; Curtiss LK; Burnett JR; Cartland SP; Quinn CM; Kockx M; Kontush A; Rye KA; Kritharides L; Jessup W
    Circ Res; 2015 Mar; 116(7):1133-42. PubMed ID: 25589556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sage weed (Salvia plebeia) extract antagonizes foam cell formation and promotes cholesterol efflux in murine macrophages.
    Park SH; Kim JL; Kang MK; Gong JH; Han SY; Shim JH; Lim SS; Kang YH
    Int J Mol Med; 2012 Nov; 30(5):1105-12. PubMed ID: 22922992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum, but not monocyte macrophage foam cells derived from low HDL-C subjects, displays reduced cholesterol efflux capacity.
    Nakanishi S; Vikstedt R; Söderlund S; Lee-Rueckert M; Hiukka A; Ehnholm C; Muilu M; Metso J; Naukkarinen J; Palotie L; Kovanen PT; Jauhiainen M; Taskinen MR
    J Lipid Res; 2009 Feb; 50(2):183-92. PubMed ID: 18787236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wogonin promotes cholesterol efflux by increasing protein phosphatase 2B-dependent dephosphorylation at ATP-binding cassette transporter-A1 in macrophages.
    Chen CY; Shyue SK; Ching LC; Su KH; Wu YL; Kou YR; Chiang AN; Pan CC; Lee TS
    J Nutr Biochem; 2011 Nov; 22(11):1015-21. PubMed ID: 21190831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propofol up-regulates expression of ABCA1, ABCG1, and SR-B1 through the PPARγ/LXRα signaling pathway in THP-1 macrophage-derived foam cells.
    Ma X; Li SF; Qin ZS; Ye J; Zhao ZL; Fang HH; Yao ZW; Gu MN; Hu YW
    Cardiovasc Pathol; 2015; 24(4):230-5. PubMed ID: 25600616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional LCAT is not required for macrophage cholesterol efflux to human serum.
    Calabresi L; Favari E; Moleri E; Adorni MP; Pedrelli M; Costa S; Jessup W; Gelissen IC; Kovanen PT; Bernini F; Franceschini G
    Atherosclerosis; 2009 May; 204(1):141-6. PubMed ID: 18922527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanism of curcumin on the suppression of cholesterol accumulation in macrophage foam cells and atherosclerosis.
    Zhao JF; Ching LC; Huang YC; Chen CY; Chiang AN; Kou YR; Shyue SK; Lee TS
    Mol Nutr Food Res; 2012 May; 56(5):691-701. PubMed ID: 22648616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesterol efflux mediators in homozygous familial hypercholesterolemia patients on low-density lipoprotein apheresis.
    Nenseter MS; Narverud I; Græsdal A; Bogsrud MP; Aukrust P; Retterstøl K; Ose L; Halvorsen B; Holven KB
    J Clin Lipidol; 2013; 7(2):109-16. PubMed ID: 23415429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epoxycholesterol impairs cholesteryl ester hydrolysis in macrophage foam cells, resulting in decreased cholesterol efflux.
    Ouimet M; Wang MD; Cadotte N; Ho K; Marcel YL
    Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1144-50. PubMed ID: 18369155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventive effects of heregulin-beta1 on macrophage foam cell formation and atherosclerosis.
    Xu G; Watanabe T; Iso Y; Koba S; Sakai T; Nagashima M; Arita S; Hongo S; Ota H; Kobayashi Y; Miyazaki A; Hirano T
    Circ Res; 2009 Aug; 105(5):500-10. PubMed ID: 19644050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin-induced decrease in ATP-binding cassette transporter A1 expression via microRNA33 induction may counteract cholesterol efflux to high-density lipoprotein.
    Niesor EJ; Schwartz GG; Perez A; Stauffer A; Durrwell A; Bucklar-Suchankova G; Benghozi R; Abt M; Kallend D
    Cardiovasc Drugs Ther; 2015 Feb; 29(1):7-14. PubMed ID: 25749868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acidic extracellular environments strongly impair ABCA1-mediated cholesterol efflux from human macrophage foam cells.
    Lee-Rueckert M; Lappalainen J; Leinonen H; Pihlajamaa T; Jauhiainen M; Kovanen PT
    Arterioscler Thromb Vasc Biol; 2010 Sep; 30(9):1766-72. PubMed ID: 20702810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholesterol efflux potential and antiinflammatory properties of high-density lipoprotein after treatment with niacin or anacetrapib.
    Yvan-Charvet L; Kling J; Pagler T; Li H; Hubbard B; Fisher T; Sparrow CP; Taggart AK; Tall AR
    Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1430-8. PubMed ID: 20448206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ability to promote efflux via ABCA1 determines the capacity of serum specimens with similar high-density lipoprotein cholesterol to remove cholesterol from macrophages.
    de la Llera-Moya M; Drazul-Schrader D; Asztalos BF; Cuchel M; Rader DJ; Rothblat GH
    Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):796-801. PubMed ID: 20075420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adiponectin increases macrophages cholesterol efflux and suppresses foam cell formation in patients with type 2 diabetes mellitus.
    Wang M; Wang D; Zhang Y; Wang X; Liu Y; Xia M
    Atherosclerosis; 2013 Jul; 229(1):62-70. PubMed ID: 23466101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.